Experience with remifentanil in neonates and infants

Remifentanil is a relatively new synthetic opioid, which is not licensed worldwide for neonates and infants. Because of its unique pharmacokinetic properties with a short recovery profile, it could be the ideal opioid for neonates and infants, who are especially sensitive to respiratory depression b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2006-01, Vol.66 (10), p.1339-1350
Hauptverfasser:	WELZING, Lars, ROTH, Bernhard
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Anesthesia - adverse effects Adjuvants, Anesthesia - pharmacokinetics Adjuvants, Anesthesia - therapeutic use Analgesics Analgesics, Opioid - adverse effects Analgesics, Opioid - pharmacokinetics Analgesics, Opioid - therapeutic use Biological and medical sciences Half-Life Humans Infant Infant, Newborn Medical sciences Metabolic Clearance Rate Neuropharmacology Pharmacology. Drug treatments Piperidines - adverse effects Piperidines - pharmacokinetics Piperidines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!